Regional Cancer Care Associates is pleased to announce the recognition of John Theurer Cancer Center as the #1 Cancer Program in New Jersey by U.S. News and World Report
TEANECK, NJ / ACCESSWIRE / August 13, 2024 / Among over 1,500 cancer programs accredited nationwide, JTCC was ranked among the Top 50 and is the only one in the state of New Jersey. We are honored by this recognition, which is a testimony to the expertise, dedication, and excellence of our colleagues and team members. This also reflects our drive for innovation and research in cancer, which not only provides our communities with the therapies of tomorrow but also helps set new standards and moves the needle in cancer overall.
This U.S. News recognition is a continuation of the acknowledgment of John Theurer Cancer Center as the largest and premier cancer program in our state. We are proud and grateful for all the relentless work at JTCC and thank our colleagues, nurses, and all the patients who have trusted us over the years.
RCCA was established in 2012 as a regional cancer network with over 100 cancer specialists providing community-based care at more than 24 centers located throughout New Jersey, Connecticut, Maryland and the Washington, DC, area. RCCA Oncologists/Hematologists provide care to over 29,000 new cancer patients and 260,000 established patients each year, collaborating closely with their patients’ other physicians as well. RCCA specialists offer those patients immunotherapy, targeted treatment, cell-based therapy and other cutting-edge treatments and diagnostic modalities, as well as access to over 400 clinical trials. We have sub-specialty care as part of John Theurer Cancer Center including a Phase I Cancer Program and one of the largest Bone Marrow Transplant and Cell Therapy programs in the nation.
Once again, we would like to congratulate our team members and colleagues for this accomplishment. We are very proud of this recognition and are looking forward to expanding our teams and locations to provide the best options closer to home.
Contact Information
Mary Campbell
EXECUTIVE ASSISTANT TO CEO AND BOARD COORDINATOR
mary.campbell1@regionalcancercare.org
201-579-9241
SOURCE: RCCA
View the original press release on newswire.com.
Vancouver, British Columbia--(Newsfile Corp. - December 18, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX:…
Brainomix 360 Stroke imaging was utilized to improve and standardize the grading of baseline stroke…
Partnership expands BC Platforms' global patient catchment to include an additional 48 million patient lives…
Prominent Japan CRO adopts new safety case processing system to further enhance compliance, automation, and…
DentScribe now safely and securely integrates with Dentrix to help dental practices build their best…
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE…